From: Reducing the incidence of stroke-associated pneumonia: an evidence-based practice
Variables | Preimplementation group (nā=ā43) | Postimplementation group (nā=ā43) | t/U /Ļ2 | P |
---|---|---|---|---|
SAP | 16 (37.2) | 6 (14.0) | 6.108 | 0.025* |
Indicators of infection | ||||
āWhite blood cells (109/L) | 7.49 (5.51, 9.30) | 7.20 (5.51, 8.40) | 863.5 | 0.598 |
āProcalcitonin (ng/ml) | 0.083 (0.054, 0.095) | 0.054 (0.044, 0.076) | 610.5 | 0.007* |
āHypersensitive C-reactive protein (mg/L) | 8.74 (4.56, 13.60) | 5.20 (3.40, 6.70) | 636.5 | 0.013* |
Length of stay, days | 13 (9, 18) | 11 (8, 14) | 687.0 | 0.040* |
Total cost, USD | 20,351.62 (12,794.51, 32,790.98) | 18,139.21 (12,658.4, 32,666.31) | 843.0 | 0.481 |
NIHSS score | 4 (2, 13) | 6 (2, 9) | 923.0 | 0.990 |
Aspiration | 16 (37.2) | 4 (9.3) | 9.382 | 0.004* |
NRS-2002 | Ā | Ā | 2.549 | 0.171 |
āĀ ā„Ā 3 | 32 (74.4) | 25 (58.1) | Ā | Ā |
āā<ā3 | 11 (25.6) | 18 (41.9) | Ā | Ā |
Serum albumin (g/L) | 33.92āĀ±ā2.90 | 35.83āĀ±ā4.20 | ā2.459 | 0.016* |
Oral hygiene score | 19 (15, 21) | 15 (13, 18) | 530.5 | 0.001* |
30āml water swallowing test | Ā | Ā | 6.766 | 0.149 |
āI | 2 (4.7) | 10 (23.3) | Ā | Ā |
āII | 15 (34.9) | 12 (27.9) | Ā | Ā |
āIII | 16 (37.2) | 15 (34.9) | Ā | Ā |
āIV | 6 (14.0) | 4 (9.3) | Ā | Ā |
āV | 4 (9.3) | 2 (4.7) | Ā | Ā |
The degree of dysphagia | Ā | Ā | 7.097 | 0.131 |
ā 0 | 2 (4.7) | 10 (23.3) | Ā | Ā |
ā 2 | 15 (34.9) | 12 (27.9) | Ā | Ā |
ā 4 | 17 (39.5) | 16 (37.2) | Ā | Ā |
ā 5 | 6 (14.0) | 4 (9.3) | Ā | Ā |
ā 6 | 3 (7.0) | 1 (2.3) | Ā | Ā |